Black R J, Bray F, Ferlay J, Parkin D M
Unit of Descriptive Epidemiology, International Agency for Research on Cancer, Lyon, France.
Eur J Cancer. 1997 Jun;33(7):1075-107. doi: 10.1016/s0959-8049(96)00492-3.
Members of the European Network of Cancer Registries (ENCR) provide population-based data on cancer incidence for some countries and regions of Europe. These were supplemented by estimates in order to provide comparable information on cancer incidence and mortality in the 15 member states of the European Union (EU). The estimated numbers of new cases of cancer (excluding nonmelanoma skin cancer) in 1990 were approximately 706,900 in men and 644,200 in women. Approximately 497,500 men and 398,200 women died of cancer in the same year. The main sites of incident cases in men were lung (21%), large bowel (13%), prostate (12%), bladder (7%) and stomach (7%). For women, the predominant sites were breast (28%), large bowel (15%), lung (6%), uterine corpus (5%) and stomach (5%). The overall incidence rates for males were highest in continental Western Europe (France, The Netherlands, Austria, Luxembourg, Belgium, Germany and Italy) while the rates of Greece, Portugal, Sweden, Ireland, Spain, Finland, the U.K. and Denmark were below the average value for the EC. Rates for females were highest in Northern and Western Europe, with the exception of France, which had a relatively low rate for females, in common with Greece, Spain and Portugal. The geographical variations in incidence of the major cancers are discussed in relation to risk factors. The estimates show the substantial burden of cancer in European Union populations, but there are also indications of effects of past preventive measures and there is scope for further intervention. Cancer registries are an important source of information for cancer control since they provide population-based incidence and survival statistics. These, along with mortality data, are required to obtain a full picture of the frequency of cancer and its effects at the population level. Some 44% of the EU population is covered by registries. The European Network of Cancer Registries aims to standardise the information provided by existing registries and to provide practical assistance to those in development.
欧洲癌症登记处网络(ENCR)的成员为欧洲的一些国家和地区提供基于人群的癌症发病率数据。为了提供欧盟15个成员国癌症发病率和死亡率的可比信息,这些数据还得到了估算值的补充。1990年,估计新增癌症病例(不包括非黑素瘤皮肤癌)数量男性约为706,900例,女性约为644,200例。同年,约497,500名男性和398,200名女性死于癌症。男性发病的主要部位是肺癌(21%)、大肠癌(13%)、前列腺癌(12%)、膀胱癌(7%)和胃癌(7%)。女性的主要发病部位是乳腺癌(28%)、大肠癌(15%)、肺癌(6%)、子宫体癌(5%)和胃癌(5%)。男性的总体发病率在西欧大陆(法国、荷兰、奥地利、卢森堡、比利时、德国和意大利)最高,而希腊、葡萄牙、瑞典、爱尔兰、西班牙、芬兰、英国和丹麦的发病率低于欧共体的平均值。女性发病率在北欧和西欧最高,但法国除外,法国女性发病率相对较低,希腊、西班牙和葡萄牙也是如此。主要癌症发病率的地理差异与风险因素相关进行了讨论。这些估算显示了欧盟人群中癌症的沉重负担,但也有过去预防措施产生效果的迹象,并且有进一步干预的空间。癌症登记处是癌症控制的重要信息来源,因为它们提供基于人群的发病率和生存统计数据。这些数据连同死亡率数据,对于全面了解癌症在人群层面的发病频率及其影响是必不可少的。约44%的欧盟人口被登记处覆盖。欧洲癌症登记处网络旨在使现有登记处提供的信息标准化,并为正在建立登记处的机构提供实际援助。